ramatroban has been researched along with Airway Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, T; Matsui, T; Ohta, A; Okamoto, Y; Shichijo, M | 1 |
| Cui, ZH; Kawikova, I; Lötvall, J; Okazawa, A; Skoogh, BE | 1 |
1 review(s) available for ramatroban and Airway Obstruction
| Article | Year |
|---|---|
Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor.
Topics: Airway Obstruction; Animals; Arteriosclerosis; Capillary Permeability; Carbazoles; Clinical Trials as Topic; Eosinophils; Humans; Nasal Mucosa; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfonamides; Thromboxane-A Synthase; Tunica Intima | 2004 |
1 other study(ies) available for ramatroban and Airway Obstruction
| Article | Year |
|---|---|
8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo.
Topics: Airway Obstruction; Animals; Bronchoalveolar Lavage Fluid; Carbazoles; Dinoprost; Guinea Pigs; Histamine Antagonists; Male; Methacrylates; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Thromboxane B2; Vasoconstrictor Agents | 1997 |